Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments (the eServices portal) close on Thursday 21 October at 4:30pm because of system upgrades. We expect to open them again on Friday 22 October at 8am the latest.

Tunable expression of genes in the brain

Reference number
Coordinator GENETUNES AB
Funding from Vinnova SEK 299 000
Project duration May 2017 - February 2018
Status Completed
Venture Innovative Startups

Purpose and goal

To increase the competitiveness of the technology for funding and further development in cooperation with investors and industry.

Expected results and effects

We have accomplished our objectives.

Planned approach and implementation

We did a thorough investigation of the stakeholders within the market för gene therapies and selected the ones that we deemed most interested in our specific type of technology and initiated contacts. Under the discussions with them, we verified the competitiveness of our technology, our freedom to operate and next necessary steps.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 20 March 2019

Reference number 2017-00081

Page statistics